Online First

  • Bioinformatics Analysis Identifies Potential Diagnostic Biomarkers of Sarcoidosis

    Linling Jin, Chunfeng Pan, Yujie Sun, Jiayi Zhang, Weiping Xie, Mengyu He
    17074
    DOI: https://doi.org/10.36141/svdld.v42i4.17074
  • A unique case of extrapulmonary sarcoidosis on F18 FDG PET/CT: “Tiger man”

    Inci Uslu Biner, Seval Aslan, Ilknur Ak Sivrikoz, Nazlı Sena Şeker
    17033
    DOI: https://doi.org/10.36141/svdld.vi.17033

Announcements

Current Issue

Vol. 42 No. 3 (2025)
Published: 30-09-2025

  • WASOG Clinical Trial Endpoint Task Force: Executive Summary

    Robert P. Baughman, Elyse E. Lower, Daniel A. Culver, Marc A. Judson, Athol U. Wells
    17859
    DOI: https://doi.org/10.36141/svdld.v42i3.17859
  • Americas Association of Sarcoidosis and other granulomatous disorders 2024 conference highlights

    Kristen R. Mathias, Anjali A. Wagle, Susana Dominguez-Peñuela, Carlos A. Pardo, Michelle Sharp, Nisha A. Gilotra
    17197
    DOI: https://doi.org/10.36141/svdld.v42i3.17197
  • Cardiac sarcoidosis recurrence post-heart transplant: A critical literature and case report

    Andrea Salotti, Lucrezia Mondini, Paola Confalonieri, Francesco Salton, Chiara Nalli, Nicolò Reccardini, Chiara Torregiani, Caterina Antonaglia, Michael Hughes, Marco Confalonieri, Rossella Cifaldi, Barbara Ruaro
    16865
    DOI: https://doi.org/10.36141/svdld.v42i3.16865
  • Residential fungal β-(1,3)-D-glucan exposure is associated with decreased pulmonary function in fibrotic pulmonary sarcoidosis.

    Emma M Stapleton, Nervana Metwali, Michael Shlossman, Linder Wendt, Alejandro A Pezzulo, Nabeel Y Hamzeh, Alejandro P Comellas, Peter S Thorne, Alicia K Gerke
    16831
    DOI: https://doi.org/10.36141/svdld.v42i3.16831
  • Use of 18F-FDG PET in assessing response to treatment in adults with pulmonary sarcoidosis: A systematic literature review

    Oliver Vij, Mathangi Krishnakumar, Helen Elwell, Mrinalini Dey, Koushan Kouranloo
    16631
    DOI: https://doi.org/10.36141/svdld.v42i3.16631
  • Survival impact and safety comparison of pirfenidone and nintedanib for idiopathic pulmonary fibrosis: A meta-analysis

    Hafiz Muhammad Ehsan Arshad, Faaz Ali, Anas Babar, Muhammad Zain Raza, Musab Maqsood, Akmal Ameer
    16432
    DOI: https://doi.org/10.36141/svdld.v42i3.16432
  • Particles exposures and sarcoidosis

    Andrew J. Ghio, Spencer A. Scott, Stephen L. Tilley
    16384
    DOI: https://doi.org/10.36141/svdld.v42i3.16384

  • Use of fatigue assessment scale and small fiber neuropathy screening list in Japanese patients with sarcoidosis

    Hiromi Tomioka, Yu Kobayashi, Masaaki Iwabayashi, Masamichi Lee, Tasuku Matsuoka, Makoto Yokota, Hisanori Amimoto, Junji Takiguchi, Masahiro Kaneko, Hiroshi Fujii
    16824
    DOI: https://doi.org/10.36141/svdld.v42i3.16824
  • Evaluation of patients diagnosed with primary Sjogren’s syndrome with and without pulmonary involvement

    Zehra Ozsoy, Tuğçe Şahin Ozdemırel, Kerem Ensarıoğlu, Hakan Erturk, Zeynep Ozturk, Hasret Yıldırım, Esma Sevil Akkurt, Esin Beyan, Umut Kalyoncu, Berna Akıncı Ozyurek
    17364
    DOI: https://doi.org/10.36141/svdld.v42i3.17364
  • Comparison of the 2022 ACR/EULAR classification criteria with the 1990 ACR classification criteria for Takayasu arteritis

    Duygu Tecer, Mehmet Nur Kaya, Özlem Kılıç, Sedat Yılmaz
    17094
    DOI: https://doi.org/10.36141/svdld.v42i3.17094
  • Diagnostic potential of serum ACE and CBC inflammatory markers in silicosis in the ceramic workers

    Dr. Bilge Akgündüz
    16985
    DOI: https://doi.org/10.36141/svdld.v42i3.16985
  • Impact of nutritional status in sarcoidosis patients

    Şeyma Tunç, Pınar Yıldız, Mehmet Ali Sungur
    16968
    DOI: https://doi.org/10.36141/svdld.v42i3.16968
  • Medication adherence and real-world factors of first line induction treatment selection in ANCA-associated vasculitis

    Pınar Akyüz Dağlı, Esra Kayacan Erdoğan, Hatice Ecem Konak, Bahar Özdemir Ulusoy, Serdar Can Güven, Berkan Armağan, Rezan Koçak Ulucaköy, Kevser Orhan, Ebru Atalar, İsmail Doğan, Yüksel Maraş, Ahmet Omma, Orhan Küçükşahin, Şükran Erten, Hakan Babaoğlu
    16880
    DOI: https://doi.org/10.36141/svdld.v42i3.16880
  • Comparison of the effectiveness of pirfenidone and nintedanib in patients with advanced stage idiopathic pulmonary fibrosis

    Guliz Degirmenci, Celal Satici, Damla Azakli Yazici, Nazim Cetinkaya, Umut Erdem, Baris Demirkol, Aysegul Erinc
    16849
    DOI: https://doi.org/10.36141/svdld.v42i3.16849
  • Effect of exercise training in patients with cardiac sarcoidosis after induction of oral corticosteroid therapy

    Hidetoshi Yanagi, Harumi Konishi, Yukihiro Shimada, Hiroyuki Miura , Tatsuo Aoki, Teruo Noguchi
    15628
    DOI: https://doi.org/10.36141/svdld.v42i3.15628
  • Clinical and radiological factors affecting progression in sarcoidosis

    Olcay Aycicek, Ensar Cihat Emiroglu, Kadir Coban, Muge Erbay, Tevfik Ozlu, Funda Oztuna, Yılmaz Bulbul
    16820
    DOI: https://doi.org/10.36141/svdld.v42i3.16820
  • The value of endobronchial ultrasound-guided transbronchial needle aspiration for the diagnosis of pulmonary sarcoidosis real life-settings

    Ibrahim Guven Cosgun, Aydin Balci, Sule Cilekar
    16693
    DOI: https://doi.org/10.36141/svdld.v42i3.16693
  • Global disease burden of interstitial lung disease and pulmonary sarcoidosis, 1990-2021, and forecast analysis over the next decade

    Xinlian Li, Zhihong Zhang
    16462
    DOI: https://doi.org/10.36141/svdld.v42i3.16462
  • A randomized trial of narrow band imaging for performing airway mucosal biopsy in pulmonary sarcoidosis (NABS)

    Kritarth Rathi, Pooja Dogra, Ritesh Agarwal, Inderpaul Singh Sehgal, Valliappan Muthu, Kuruswamy Thurai Prasad, Ashutosh Nath Aggarwal, Amanjit Bal, Nalini Gupta, Sahajal Dhooria
    16418
    DOI: https://doi.org/10.36141/svdld.v42i3.16418
  • Association of non-linear dynamics of heart rate variability with all-cause mortality in patients with sarcoidosis

    Elias Giallafos, Ioannis Ilias, Spiros Katsanos, Likourgos Kolilekas, Efrosini Manali, Aglaia Vakrakou, Theodore Papaioannou, Kostas Zisimos, Gethsimani Seitaridi, Giannis Parisis, Nikos Koulouris, Spiros Papiris
    16332
    DOI: https://doi.org/10.36141/svdld.v42i3.16332

  • Classic imaging in cardiac sarcoidosis

    Apoorwa Thati, Erika Hutt, Christine Jellis, Manuel L. Ribeiro Neto
    16548
    DOI: https://doi.org/10.36141/svdld.v42i3.16548

  • Eosinophil-associated disease after SARS-CoV-2 infection or vaccination: EGPA and related entities

    Ghadah A. Alrehaili, Karina A. Keogh, Misbah Baqir
    16598
    DOI: https://doi.org/10.36141/svdld.v42i3.16598
View All Issues